Maureen O’Brien, MD, MS Medical Director of the Leukemia/Lymphoma Program Cincinnati Children’s Hospital Medical Center Associate Professor of Clinical Pediatrics University of Cincinnati College of Medicine Dr. O’Brien is the Medical Director of the Leukemia/Lymphoma Program at Cincinnati Children’s Hospital […]
Maureen O’Brien, MD, MS Read More »
Lori Styles, MD Senior Medical Director in Clinical Development Oncology Abbvie Dr. Styles is a Senior Medical Director in Clinical Development Oncology at Abbvie. She received her MD from the University of California, San Diego School of Medicine. She completed
Dr. Geoffrey Kannan has always known he wanted to be a physician-scientist. After his first laboratory experience in high school, he was dedicated to learning more about innovations in science that could impact patients’ lives. “As soon as I stepped
Industry Advisory Council Spotlight: Geoffrey Kannan, MD, PhD Read More »
CureSearch focuses on accelerating innovative research that will better treat cancers like Beau’s bone-eating Ewing sarcoma. At CureSearch, we believe no cancer is too rare to receive funding and in that message is hope. Donate to Beau’s Fund Fundraise for
Home PageSam’s StoryThe Yellow JerseyEventsKeep in TouchDonate to Sam’s Legacy Fund Hear Sam’s Story, in his own words. A heartfelt thank you to our supporters CONIFER RADIO Beth and Kelly were recently interviewed on Conifer Radio’s podcast. Listen now to
Projects will develop new treatments for neuroblastoma, high-grade gliomas, including DMG, and more Bethesda, Md. – February 15, 2022– CureSearch for Children’s Cancer, a national nonprofit with a mission to end childhood cancer by driving targeted and innovative research with measurable results
CureSearch announces new funding commitment to childhood cancer research projects Read More »
DAVID LANGENAU, PhD Massachusetts General Hospital in collaboration with Duke University School of Medicine, The Hospital for Sick Children and the National Institutes of Health CureSearch Acceleration Initiative Award: 2022-2025 Focus: Rhabdomyosarcoma Project title: Targeting p53 in childhood rhabdomyosarcoma About Dr. Langenau
DAVID LANGENAU, PhD – ACCELERATION INITIATIVE – RHABDOMYOSARCOMAma Read More »
GREGORY FRIEDMAN, MD MD Anderson Cancer Center in collaboration with Avidea Technologies, Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard, Harvard Medical School, Brigham and Women’s and Boston Children’s Hospital, University of Cambridge, Northwestern University, Lurie Children’s Hospital and
Gregory Friedman, MD – Acceleration Initiative – Pediatric High-Grade Gliomas Read More »
Justin Wahlstrom, pediatric development lead in AbbVie oncology, is a physician trained in pediatric hematology/oncology and hematopoietic stem cell transplantation, and has led clinical development efforts in pediatric oncology across multiple assets since 2017. Prior to joining Abbvie in 2017,
Geoffrey Kannan, MD, PhD Executive Medical Director, Head of Americas Oncology Team Fortrea Geoffrey Kannan, MD, PhD, is the Executive Medical Director, Head of Americas Oncology Team at Fortrea. Dr. Kannan serves as a medical monitor in a wide variety
Geoffrey Kannan, MD, PhD Read More »
